Wells Samuel A, Debenedetti Mary K, Doherty Gerard M
Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Bone Miner Res. 2002 Nov;17 Suppl 2:N158-62.
Approximately 90% of patients with primary hyperparathyroidism (PHPT) are cured by parathyroidectomy at the initial neck exploration. Those not cured either remain hypercalcemic in the immediate postoperative period or develop hypercalcemia after a long period of normocalcemia. Almost all cases of hypercalcemia after neck exploration for PHPT are evident early in the postoperative period and are caused either by an overlooked parathyroid adenoma or an incomplete resection of hyperplastic parathyroid tissue. Less commonly, the surgeon has failed to recognize, and adequately treat, parathyroid carcinoma, or the diagnosis of PHPT was incorrect and there is another cause of the hypercalcemia. A successful neck exploration for PHPT is primarily dependent on the experience of the operating surgeon, the anatomic location of the parathyroid glands, either in "normal" or "ectopic" sites, and the presence of a single enlarged parathyroid gland as opposed to multiglandular disease or parathyroid carcinoma. In cases where an enlarged parathyroid gland is not identified at operation, noninvasive or invasive radiographic imaging procedures are useful in localizing the gland. Currently, the most reliable and practical procedure is technetium 99m sestamibi scanning. This technique identifies an enlarged parathyroid gland in 65-80% of cases. Single photon emission computed tomography (SPECT) in association with sestamibi scanning increases the sensitivity of the procedure to 85%. These imaging procedures are least reliable in patients with multiglandular disease. Ultrasound and computed tomographic scanning are less sensitive; however, they are commonly used as confirmatory tests in association with sestamibi scanning. When noninvasive imaging procedures fail to identify an enlarged parathyroid gland, invasive procedures, such as selective arteriography, are performed. Whereas invasive procedures are useful, they are associated with significant morbidity. Reoperations for persistent or recurrent hyperparathyroidism, compared with the initial operations, are associated with higher complication rates. In 90% of cases, the abnormal pathology can be reached through a cervical incision. The success rate of the reoperation depends primarily on the results of the localization procedure and whether the patient has a single enlarged parathyroid gland or multiglandular disease. Resection of a single enlarged gland is curative in virtually all patients. If, however, the patient has multiple gland disease, the operation is successful less often, especially in those with certain familial endocrinopathies.
约90%的原发性甲状旁腺功能亢进症(PHPT)患者在初次颈部探查行甲状旁腺切除术后可获治愈。未治愈的患者要么在术后短期内仍存在高钙血症,要么在长期血钙正常后又出现高钙血症。几乎所有因PHPT行颈部探查术后发生高钙血症的病例在术后早期即很明显,其原因要么是遗漏了甲状旁腺腺瘤,要么是增生的甲状旁腺组织切除不完全。较少见的情况是,外科医生未能识别并充分治疗甲状旁腺癌,或者PHPT的诊断有误,高钙血症另有其因。PHPT颈部探查术的成功主要取决于手术医生的经验、甲状旁腺的解剖位置(无论是在“正常”还是“异位”部位),以及是否存在单个增大的甲状旁腺,而非多腺体疾病或甲状旁腺癌。在手术中未发现增大的甲状旁腺的情况下,非侵入性或侵入性放射影像学检查方法有助于定位该腺体。目前,最可靠且实用的方法是锝99m甲氧基异丁基异腈扫描。该技术在65% - 80%的病例中可识别出增大的甲状旁腺。单光子发射计算机断层扫描(SPECT)联合甲氧基异丁基异腈扫描可将该检查的敏感性提高至85%。这些影像学检查方法在多腺体疾病患者中最不可靠。超声和计算机断层扫描敏感性较低;然而,它们通常与甲氧基异丁基异腈扫描联合用作确认性检查。当非侵入性影像学检查方法未能识别出增大的甲状旁腺时,会进行侵入性检查,如选择性动脉造影。虽然侵入性检查方法有用,但它们会带来显著的发病率。与初次手术相比,持续性或复发性甲状旁腺功能亢进症的再次手术并发症发生率更高。在90%的病例中,可通过颈部切口找到异常病变。再次手术的成功率主要取决于定位检查的结果以及患者是有单个增大的甲状旁腺还是多腺体疾病。切除单个增大的腺体几乎可治愈所有患者。然而,如果患者有多腺体疾病,手术成功的几率较低,尤其是在患有某些家族性内分泌病的患者中。